Replies to post #19244 on GTC Biotherapeutics (fka GTCB)

[biopearl]

Thanks for the correction pharm, its nice to see signs of life out there. I fear I have lost two good friends who now barely talk to me, I suggested they look into this stock years ago. Here is what I continue to see for 2010: actual Atryn sales, resolution with Leo in favor of GTCB, partner for heparin indication and DIC, entry of Fx 7a into clinical testing, possible merger with LFB that finally recognizes intrinsic value of outstanding shares and give value to at least some of the options held by administration. I am perplexed why a disease like septic shock would continue to be treated with human plasma derive products in Europe and Japan in the era of Atryn. bp